{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T09:21:47Z","timestamp":1649150507193},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2000,3]]},"DOI":"10.1007\/s11886-000-0003-8","type":"journal-article","created":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T10:59:14Z","timestamp":1180695554000},"page":"87-89","source":"Crossref","is-referenced-by-count":1,"title":["Beta-blockers and spironolactone in heart failure"],"prefix":"10.1007","volume":"2","author":[{"given":"Marrick L.","family":"Kukin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"3_CR1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","volume":"353","author":"CIBIS-II Investigators and Committees","year":"1999","unstructured":"CIBIS-II Investigators and Committees: The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999, 353:9\u201313. Double blind placebo-controlled trial with 2647 patients in NYHA class III\/IV heart failure using the \u03b2-1 selective bisoprolol showing a 34% reduction in mortality (P < 0.0001).","journal-title":"Lancet"},{"key":"3_CR2","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","volume":"353","author":"The MERIT-HF Study Group","year":"1999","unstructured":"The MERIT-HF Study Group: Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999, 353:2001\u20132007. Double blind placebo-controlled trial with 3991 patients in NYHA class II\/III heart failure using the \u03b2-1 selective extended release metoprolol succinate showing a 34% reduction in mortality (P=0.00009).","journal-title":"Lancet"},{"key":"3_CR3","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","volume":"334","author":"M Packer","year":"1996","unstructured":"Packer M, Bristow MR, Cohn JN, et al.: for The US Carvedilol Heart Failure Study Group: The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996, 334:1349\u20131355.","journal-title":"N Engl J Med"},{"issue":"suppl 2A","key":"3_CR4","first-page":"17A","volume":"83","author":"M Packer","year":"1999","unstructured":"Packer M, Cohn JN, on behalf of the steering committee and membership of the advisory council to improve outcomes nationwide in heart failure: Consensus recommendations for the management of heart failure. Am J Cardiol 1999, 83(suppl 2A):17A-22A. Consensus document with extensive references detailing the evidence for current therapy in outpatient chronic heart failure.","journal-title":"Am J Cardiol"},{"key":"3_CR5","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1136\/hrt.37.10.1022","volume":"37","author":"F Waagstein","year":"1975","unstructured":"Waagstein F, Hjalmarson A, Varnauskas E, et al.: Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J 1975, 37:1022\u20131036.","journal-title":"Br Heart J"},{"key":"3_CR6","unstructured":"Domanski M, Eichhorn E: Beta-blocker Evaluation Survival Trial-BEST: Oral presentation Late Breaking Clinical Trials, AHA meeting Nov. 10, Atlanta, Ga.1999,"},{"key":"3_CR7","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/hrt.79.1.86","volume":"79","author":"JE Sanderson","year":"1998","unstructured":"Sanderson JE, Chan SKW, Yu CM, et al.: blockers in heart failure: a comparison of a vasodilating b blocker with metoprolol. Heart 1998, 79:86\u201392.","journal-title":"Heart"},{"issue":"suppl I","key":"3_CR8","first-page":"577","volume":"96","author":"M Metra","year":"1997","unstructured":"Metra M, Nodari S, Garbellini M, et al.: Comparative effects of metoprolol and carvedilol on resting and peak exercise hemodynamics and functional capacity in patients with chronic heart failure. Circulation 1997, 96:(suppl I):577\u2013578.","journal-title":"Circulation"},{"key":"3_CR9","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1161\/01.CIR.99.20.2645","volume":"99","author":"ML Kukin","year":"1999","unstructured":"Kukin ML, Kalman J, Charney RH, et al.: Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure. Circulation 1999, 99:2645\u20132651. First direct prospective comparison of the b-1 selective metoprolol tartrate and the b nonselective, a-locking carvedilol showing similar beneficial effects in clinical and antioxidant measures.","journal-title":"Circulation"},{"key":"3_CR10","first-page":"153","volume":"5","author":"R Moskowitz","year":"1999","unstructured":"Moskowitz R, Kukin M: Oxidative stress and congestive heart failure. Congestive Heart Failure 1999, 5:153\u2013163.","journal-title":"Congestive Heart Failure"},{"key":"3_CR11","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/S0735-1097(99)00367-8","volume":"34","author":"JE Sanderson","year":"1999","unstructured":"Sanderson JE, Chan SKW, Yip G, et al.: Beta-blockade in heart failure. A comparison of carvedilol with metoprolol. J Am Coll Cardiol 1999, 34:1522\u20131528.","journal-title":"J Am Coll Cardiol"},{"key":"3_CR12","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/S0735-1097(99)00134-5","volume":"33","author":"Lenarda A Di","year":"1999","unstructured":"Di Lenarda A, Sabbadini G, Salvatore L, et al.: Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. J Am Coll Cardiol 1999, 33:1926\u20131934.","journal-title":"J Am Coll Cardiol"},{"key":"3_CR13","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannaad F, Remme WJ, et al.: The effect of spironolactone on morbidity and mortality in patients with severe heart failure (RALES). N Engl J Med 1999, 341:709\u2013717. Double blind placebo-controlled trial in 1663 patients showing a 30% reduction in mortality in NYHA class III\/IV patients taking spironolactone 25 mg daily.","journal-title":"N Engl J Med"},{"key":"3_CR14","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/01.CIR.83.6.1849","volume":"83","author":"KT Weber","year":"1991","unstructured":"Weber KT, Brilla CG: Pathologic hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation 1991, 83:1849\u20131865.","journal-title":"Circulation"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-000-0003-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-000-0003-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-000-0003-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:49:34Z","timestamp":1559432974000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-000-0003-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["3"],"URL":"https:\/\/doi.org\/10.1007\/s11886-000-0003-8","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,3]]}}}